Cover Image
市場調查報告書

院內感染疾病:全球臨床實驗檢討

Nosocomial Infections Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 322149
出版日期 內容資訊 英文 103 Pages
訂單完成後即時交付
價格
Back to Top
院內感染疾病:全球臨床實驗檢討 Nosocomial Infections Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月31日 內容資訊: 英文 103 Pages
簡介

本報告提供院內感染疾病的臨床實驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 院內感染疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染疾病臨床實驗上院內感染疾病所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病臨床實驗上院內感染疾病所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

院內感染疾病治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • AstraZeneca PLC
    • Merck & Co., Inc.
    • Bayer AG
    • Tetraphase Pharmaceuticals Inc.
    • Janssen Pharmaceuticals, Inc.
    • Johnson & Johnson
    • Cubist Pharmaceuticals, Inc.
    • Janssen Research & Development, LLC
    • Achaogen Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Oxford
    • Mashhad University of Medical Sciences
    • Department of Health, UK
    • Medical University of Warsaw
    • Rigshospitalet
    • Hopitaux Universitaires de Geneve
    • University of Calgary
    • U.S. Department of Veterans Affairs
    • Duke University
    • University of Cincinnati

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2489CTIDB

GlobalData's clinical trial report, "Nosocomial Infections Global Clinical Trials Review, H2, 2014" provides data on the Nosocomial Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nosocomial Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nosocomial Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Nosocomial Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Nosocomial Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Nosocomial Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Nosocomial Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Nosocomial Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Tetraphase Pharmaceuticals Inc.
      • Clinical Trial Overview of Tetraphase Pharmaceuticals Inc.
      • Janssen Pharmaceuticals, Inc.
      • Clinical Trial Overview of Janssen Pharmaceuticals, Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Janssen Research & Development, LLC
      • Clinical Trial Overview of Janssen Research & Development, LLC
      • Achaogen Inc.
      • Clinical Trial Overview of Achaogen Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Mashhad University of Medical Sciences
      • Clinical Trial Overview of Mashhad University of Medical Sciences
      • Department of Health, UK
      • Clinical Trial Overview of Department of Health, UK
      • Medical University of Warsaw
      • Clinical Trial Overview of Medical University of Warsaw
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • Hopitaux Universitaires de Geneve
      • Clinical Trial Overview of Hopitaux Universitaires de Geneve
      • University of Calgary
      • Clinical Trial Overview of University of Calgary
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Duke University
      • Clinical Trial Overview of Duke University
      • University of Cincinnati
      • Clinical Trial Overview of University of Cincinnati
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Nosocomial Infections Therapeutics, Global, Clinical Trials by Region, 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Nosocomial Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Nosocomial Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Nosocomial Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Nosocomial Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Nosocomial Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Nosocomial Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Nosocomial Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Nosocomial Infections Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Nosocomial Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Tetraphase Pharmaceuticals Inc., 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceuticals, Inc., 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Research & Development, LLC, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Achaogen Inc., 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Warsaw, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014*

List of Figures

  • Nosocomial Infections Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Nosocomial Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Nosocomial Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Nosocomial Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Nosocomial Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Nosocomial Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Nosocomial Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Nosocomial Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Nosocomial Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Nosocomial Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top